Frontiers in Plasma Proteome Profiling Platforms: Innovations and Applications

Area of Science:

• Biochemistry
• Proteomics
• Biomarker Discovery

Background:

• Precision medicine relies on biomarkers for targeted diagnosis and treatment.
• Plasma and serum proteomics face challenges in sensitivity and quantification due to complexity and high protein abundance ranges.
• Current manual workflows hinder large-scale biomarker discovery studies.

Approach:

• Compared various plasma proteomic profiling workflows for sensitivity, reproducibility, and automation.
• Evaluated the SeerProteographXT workflow for its efficiency in handling complex biofluid samples.
• Focused on developing a methodology suitable for large cohort studies in biomarker discovery.

Key Points:

• The SeerProteographXT workflow demonstrated superior plasma proteome depth, quantitative accuracy, and reproducibility.
• This automated workflow efficiently prepares samples and is versatile across different biofluids.
• Quantified proteins include key immune molecules like interleukins and chemokines, vital for disease detection.

Conclusions:

• SeerProteographXT is a sensitive, reproducible, and automated solution for plasma proteomic profiling.
• The workflow facilitates the discovery of novel biomarkers from complex biofluids for early disease detection.
• This advancement supports improved patient care through precision medicine initiatives.